Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of the FV:Q506 mutation in unselected oncology patients.

The American journal of medicine - 1 Oct 1996

Otterson G A, Monahan B P, Harold N, Steinberg S M, Frame J N, Kaye F J

Abstract excerpt

PURPOSE: A common germline mutation in the factor V gene (FV:Q506) has been associated with hypercoagulability in families with heritable predisposition to thrombosis. We examined the prevalence and clinical significance of the FV:Q506 mutation in cancer patients. PATIENTS AND METHODS: We performed a retrospective cohort study by examining 353 consecutive, unselected patients in a general hematology/oncology...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Alleles

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Heterozygote

Share to Neoplasms

Share to Nucleic Acid Hybridization

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 8873512
DOI: 10.1016/S0002-9343(96)00235-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of the FV:Q506 mutation in unselected oncology patients.PMID 8873512Read ↗

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.Semantic proximity Read ↗

Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.Semantic proximity Read ↗

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).Semantic proximity Read ↗

Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?Semantic proximity Read ↗

Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapy.Semantic proximity Read ↗

Impact of the mutation profile on thrombotic risk in cancer patients.Semantic proximity Read ↗

Thrombosis Rates and Genetic Thrombophilia Risk Among Patients With Advanced Germ Cell Tumors Treated With Chemotherapy.Semantic proximity Read ↗

The factor V leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients1.Semantic proximity Read ↗

Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients.Semantic proximity Read ↗

The factor V Leiden mutation in children with cancer and thrombosis.Semantic proximity Read ↗

Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma.Semantic proximity Read ↗

Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.